New Delhi: If the cough continues for more than two-three weeks, one must choose to investigate tuberculosis and other conditions, the UNI Ministry of Health in Revised Guidelines issued by AIIMS, ICMR National Task Force – Covid-19 (DGHS) for patient management Covid-19 adults on Monday.
HRCT’s chest has been recommended only if there is symptom burning, the guidelines are declared further.
The doctors, meanwhile, it was recommended to avoid giving steroids to Covid-19 patients.
“There is no evidence for the benefits for injection steroids in those who do not require oxygen supplementation, or in continuation after removing anti-inflammatory therapy or immunomodulators (such as steroids) can have a risk of secondary infections such as invasive mucatorcosis when used too early, at higher doses or longer than what is needed, “this guideline is stated.
#Indiefightscorona: 📢 The latest clinical guide for Adult Management # Covid19 patients! ️ For further details: …
https://t.co/m26sihkbnB- #IndiaFightscorona (@CovidNewsBymib) 1619113934000throse over the age of 60 years, or those who have cardiovascular disease, hypertension and coronary artery diabetes mellitus and immunocompromised countries Others, such as HIV, active tuberculosis, chronic lungs, kidney or liver disease, cerebrovascular disease or high-risk obesity for severe diseases and stated guidelines.
Read Norma Junsimr Junk Antivirus oral, antibiotikoral antibiotics, antibiotics, monoclonal antibodies and vitamins have no place in the latest Covid management guidelines India, which are installed on the website of the Ministry of Health Union on Monday.
Antivirus remedies, which are given through DRIP IV, are recommended for severe patients to severe on the ICMR guidelines also stated that patients with minor diseases require symptomatic treatment for fever and pain and, if needed, corticosteroidal nose spray (budesonide).
CT scans and expensive blood tests are only recommended for medium patients who are very seriously ill.
In the guidelines, it is also stated that under anti-inflammatory or immunomodulator therapy, “injection of methylprednisolone 0.5 to 1 mg / kg in two divided doses or equivalent dexacetason doses can be given usually for a duration of 5 to 10 days in these improving patients Medium.
But if low breathing and patients with increased oxygen requirements Intubation must be prioritized in patients with high-work respiratory and methylprednisolone injection 1 to 2 mg / kg IV in 2 Dexamethasone divided or dexametent doses usually for duration 5 to 10 days, the guidelines are expressed.
Patients Positively tested has been divided into three categories: mild, medium and severe disease, but none of the categories that have been recommended for drugs such as ivermectin, favipirailavir and doxycycline.
Antivirus like molnupiravir.
and monoclonal antibodies are also not included in the guidelines.
According to Revision guidelines continue to recommend EUA or OFF Labe SA Yes using remedies in patients with ‘medium to severe’ can be considered with 10 days of symptoms.
Tocilizumab can be considered only with certain conditions of severe Covid-19 conditions, those who need oxygen supplementation and do not respond adequately for steroids.
These drugs are needed in just 24-48 hours after the emergence of severe diseases is hospitalized or in the ICU receipt.
In the guidelines, it has been mentioned that over the 60 years of their patients with cardiovascular disease, hypertension, and cad diabetes mellitus and other immunocompromised countries (such as HIV) active tuberculosis of chronic lungs / kidney / liver disease, cerebrovascular disease, obesity will be considered as a risk high for severe diseases or mortality.
(With input from the agency)